Lurasidone

CAS 29110-48-3brhrbrAntihypertensive and Treatment of ADHD

CAS 133454-47-4brhrbrAntipsychitic

CAS 71-81-8brhrbrAnticholinergic

CAS 32780-64-6brhrbrAntihypertensive

CAS 144481-98-1brhrbrAntiarrhythmic

CAS 23672-07-3brhrbrAntipsychotic

Antiemetic

Antiemetic

CAS 41100-52-1brhrbrAnti Alzhheimer

CAS 5588-10-3brhrbrBronchodilator

Anti-osteoperosis

CAS 3200-06-4brhrbrVasoditator

After another year of impressive nominations for the CPHI Pharma Awards our winners were announced at CPHI Barcelona in October 2023. In this series of interviews, we speak to the people and teams behind the award-winning projects, concepts, technologies, and in this case, the CEOs that make a difference. 

We are extremely proud and happy with this CPhI Edition, not only from business point of view, but also for the recognition received at the CPhI Pharma Awards. Enthusiasm, insightful conversations, and shared passion are the keyword for this CPhI Barcelona, and we can't thank you enough for your support.

Dr. Enrico Zodio, CEO of Procos S.p.a, speaks with CPHI TV at CPHI Worldwide in Madrid.